ABSTRACT
The co-occurrence of human immunodeficiency virus and malaria presents a complex medical scenario, significantly impacting the quality of life for affected individuals. This comprehensive review synthesizes current knowledge, challenges, and strategies concerning the concurrent management of these infections to improve overall well-being. Epidemiological insights reveal the prevalence and demographic trends, highlighting geographical areas of concern and socioeconomic factors contributing to the burden of co-infection. Pathophysiological interactions elucidate the compounding effects, altering disease progression and treatment outcomes. Healthcare challenges underscore the necessity for integrated care models, evaluating existing healthcare frameworks and their efficacy in addressing dual infections. In-depth analysis of interventions explores pharmacological, behavioral, and preventive measures, evaluating their efficacy and safety in co-infected individuals. Additionally, the review assesses psychosocial support mechanisms, emphasizing community-based interventions and peer networks in enhancing holistic care. Consideration is given to the role of antiretroviral therapy, malaria prevention strategies, and the evolving landscape of healthcare delivery in optimizing outcomes for this vulnerable population. The paper concludes by emphasizing the significance of multidisciplinary approaches and integrated care models, stressing the need for continued research and collaborative efforts to advance interventions and improve the quality of life for those navigating the complexities of human immunodeficiency virus and malaria co-infection.
Subject(s)
Coinfection , HIV Infections , Malaria , Humans , HIV , Quality of Life , Coinfection/epidemiology , Malaria/drug therapy , Malaria/epidemiology , HIV Infections/complications , HIV Infections/drug therapy , HIV Infections/epidemiologyABSTRACT
This review delves into the intricate relationship between anemia, iron metabolism, and human immunodeficiency virus (HIV), aiming to unravel the interconnected pathways that contribute to the complex interplay between these 3 entities. A systematic exploration of relevant literature was conducted, encompassing studies examining the association between anemia, iron status, and HIV infection. Both clinical and preclinical investigations were analyzed to elucidate the underlying mechanisms linking these components. Chronic inflammation, a hallmark of HIV infection, disrupts iron homeostasis, impacting erythropoiesis and contributing to anemia. Direct viral effects on bone marrow function further compound red blood cell deficiencies. Antiretroviral therapy, while essential for managing HIV, introduces potential complications, including medication-induced anemia. Dysregulation of iron levels in different tissues adds complexity to the intricate network of interactions. Effective management of anemia in HIV necessitates a multifaceted approach. Optimization of antiretroviral therapy, treatment of opportunistic infections, and targeted nutritional interventions, including iron supplementation, are integral components. However, challenges persist in understanding the specific molecular mechanisms governing these interconnected pathways. Decoding the interconnected pathways of anemia, iron metabolism, and HIV is imperative for enhancing the holistic care of individuals with HIV/AIDS. A nuanced understanding of these relationships will inform the development of more precise interventions, optimizing the management of anemia in this population. Future research endeavors should focus on elucidating the intricate molecular mechanisms, paving the way for innovative therapeutic strategies in the context of HIV-associated anemia.
Subject(s)
Anemia , Anti-HIV Agents , HIV Infections , Humans , Iron , HIV Infections/complications , HIV Infections/drug therapy , HIV Infections/epidemiology , HIV , Anemia/drug therapy , Anti-HIV Agents/therapeutic useABSTRACT
Antimicrobial properties of plants have been investigated by a number of studies worldwide and many of them have been used as therapeutic alternatives because of their antimicrobial properties. The quest for suitable and affordable alternative in the face of increasing antimicrobial drug resistant has led researchers into exploring the use of plant extract in the treatment of infections. The antibacterial properties of turmeric (Curcuma longa) on selected bacteria were evaluated. Different concentrations of turmeric extract (100, 50, 25, and 12.5 mg/mL) were prepared using 2 solvents namely water and ethanol. The antibacterial activity was tested against Bacillus species, Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa at different concentration of the extract using disc diffusion method and ciprofloxacin was the control. The zones of inhibition exhibited by ethanol and aqueous extracts against test organisms ranged from 1 to 10 mm. the ethanolic extracts were more effective than the aqueous extracts exhibiting zones of inhibition ranging from 3 to 10 mm against Bacillus species, 4 to 9 mm against S aureus, and 1 to 7 mm against E coli. There was no inhibitory effect against P aeruginosa. There was significant difference between the ethanol and aqueous extracts (Pâ < .05). This study reveal that Turmeric plant has antibacterial potential against selected organisms and may be of great use of pharmaceutical industries for the development of medicine to cure ailments and control abnormal serum lipid profile.
Subject(s)
Anti-Infective Agents , Curcuma , Humans , Escherichia coli , Microbial Sensitivity Tests , Anti-Bacterial Agents/pharmacology , Plant Extracts/pharmacology , Anti-Infective Agents/pharmacology , Ethanol/pharmacology , Bacteria , WaterABSTRACT
Human immunodeficiency virus (HIV) infection is a public health challenge that can degenerate into acquired immunodeficiency syndrome (AIDS) if not properly managed. HIV infection shortens life expectancy to about 5 to 10 years compared to noninfected individuals. People living with HIV/AIDS (PLWHA) are prone to several health challenges as a result of a deranged immune system culminating in high morbidity and mortality. Depression is a common feature of PLWHA. Depression heightens the emergence of opportunistic infections in HIV-infected individuals, accelerates the progression to AIDS, and increased suicidal tendencies, morbidity, and mortality. Food insecurity with its resultant undernutrition contributes to HIV/AIDS-related deaths. Undernourished PLWHA are more prone to opportunistic infections due to poor immunity. Interestingly, proper diet intake can boost immunity, slow the progression of AIDS and opportunistic infections, enhance body weight, and retard depression tendencies. Undernutrition can also be ameliorated by incorporating nutritional counseling and oral nutrient supplementation in routine HIV/AIDS checkups. Therefore, to increase HIV/AIDS management outcomes, the integration of nutrition counseling, dietary supplements, and mental health services should be embraced. Thus, HIV/AIDS care centers should amplify these services. In this article, we isolated relevant studies from various databases, illuminated the interwoven relationship between HIV/AIDS, depression, and undernutrition, and also reemphasized the need for adequate nutritional intervention in the battle against HIV/AIDS. Thus, this study provides a reawakening call to focus on incorporating nutritional guides and mental health care in HIV/AIDS management protocols.